|
Mar 11
|
INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
|
|
Mar 5
|
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
|
|
Mar 4
|
MannKind Corporation Announces Participation at Upcoming Conferences
|
|
Mar 3
|
Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts
|
|
Jan 2
|
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
|
|
Dec 28
|
MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 3
|
Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years
|
|
Aug 28
|
12 Best High Risk Penny Stocks to Buy Now
|
|
Aug 22
|
When Will MannKind Corporation (NASDAQ:MNKD) Breakeven?
|